Corcept Therapeutics Inc (NASDAQ: CORT) kicked off on Monday, up 3.34% from the previous trading day, before settling in for the closing price of $56.01. Over the past 52 weeks, CORT has traded in a range of $20.84-$75.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 17.73%. While this was happening, its average annual earnings per share was recorded 55.26%. With a float of $93.18 million, this company’s outstanding shares have now reached $105.11 million.
Let’s determine the extent of company efficiency that accounts for 500 employees. In terms of profitability, gross margin is 98.39%, operating margin of 20.29%, and the pretax margin is 23.92%.
Corcept Therapeutics Inc (CORT) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Corcept Therapeutics Inc is 11.68%, while institutional ownership is 80.23%. The most recent insider transaction that took place on Mar 10 ’25, was worth 117,920. In this transaction Director of this company sold 2,200 shares at a rate of $53.60, taking the stock ownership to the 0 shares. Before that another transaction happened on Mar 10 ’25, when Company’s Director proposed sale 2,200 for $53.60, making the entire transaction worth $117,920.
Corcept Therapeutics Inc (CORT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.41 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 55.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 67.21% during the next five years compared to 9.89% growth over the previous five years of trading.
Corcept Therapeutics Inc (NASDAQ: CORT) Trading Performance Indicators
Take a look at Corcept Therapeutics Inc’s (CORT) current performance indicators. Last quarter, stock had a quick ratio of 3.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.05. Likewise, its price to free cash flow for the trailing twelve months is 31.17.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.23, a number that is poised to hit 0.15 in the next quarter and is forecasted to reach 3.54 in one year’s time.
Technical Analysis of Corcept Therapeutics Inc (CORT)
Looking closely at Corcept Therapeutics Inc (NASDAQ: CORT), its last 5-days average volume was 0.97 million, which is a drop from its year-to-date volume of 1.04 million. As of the previous 9 days, the stock’s Stochastic %D was 54.05%. Additionally, its Average True Range was 3.20.
During the past 100 days, Corcept Therapeutics Inc’s (CORT) raw stochastic average was set at 48.11%, which indicates a significant increase from 44.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.49% in the past 14 days, which was lower than the 53.25% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $60.42, while its 200-day Moving Average is $46.69. However, in the short run, Corcept Therapeutics Inc’s stock first resistance to watch stands at $59.24. Second resistance stands at $60.59. The third major resistance level sits at $62.71. If the price goes on to break the first support level at $55.77, it is likely to go to the next support level at $53.65. Should the price break the second support level, the third support level stands at $52.30.
Corcept Therapeutics Inc (NASDAQ: CORT) Key Stats
The company with the Market Capitalisation of 6.11 billion has total of 105,503K Shares Outstanding. Its annual sales at the moment are 675,040 K in contrast with the sum of 141,210 K annual income. Company’s last quarter sales were recorded 181,890 K and last quarter income was 30,750 K.
